Cellenkos Inc. Enters Regulatory T-Cell Platform Research Collaboration with MD Anderson
Cellenkos Inc. has announced a multi-year collaboration with The University of Texas MD Anderson Cancer Center focused on development of cord blood regulatory T cell (CB TREG) therapeutics for treatment of autoimmune disease and inflammatory disorders. As part of this collaboration, Cellenkos Inc. - November 15, 2017
Press Releases 1 - 1 of 1